A strategy for developing effective amyotropic lateral sclerosis pharmacotherapy: from clinical trials to novel pharmacotherapeutic strategies

Author： Yamamoto Masahiko Tanaka Fumiaki Tatsumi Hiroshi Sobue Gen

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.9, Iss.11, 2008-08, pp. : 1845-1857

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting angiogenin in therapy of amyotropic lateral sclerosis

By Kishikawa Hiroko Wu David Hu Guo-fu

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 10, 2008-10 ,pp. : 1229-1242

Informa Healthcare

Access to resources Recommend Favorite

Current clinical trials in amyotrophic lateral sclerosis

By Bhatt Jaydeep M Gordon Paul H

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 8, 2007-08 ,pp. : 1197-1207

Informa Healthcare

Access to resources Recommend Favorite

Current pharmacological management of amyotropic lateral sclerosis and a role for rational polypharmacy

By Weiss Michael D Weydt Patrick Carter Gregory T

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 4, 2004-04 ,pp. : 735-746

Informa Healthcare

Access to resources Recommend Favorite

Prospects for the Pharmacotherapy of Amyotrophic Lateral Sclerosis: Old Strategies and New Paradigms for the Third Millennium

By Festoff B.W. Suo Z. Citron B.A.

CNS Drugs, Vol. 17, Iss. 10, 2003-01 ,pp. : 699-717

Adis International

Access to resources Recommend Favorite

Emerging disease-modifying therapies for the treatment of motor neuron disease/amyotropic lateral sclerosis

By Bedlack Richard S Traynor Bryan J Cudkowicz Merit E

Expert Opinion on Emerging Drugs, Vol. 12, Iss. 2, 2007-05 ,pp. : 229-252

Informa Healthcare

Access to resources Recommend Favorite